Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes
ABSTRACT: Cholesterol in the circulation is partly driven by changes in feed intake, but aspects of cholesterol metabolism during development of fatty liver are not well known. The objective of this study was to investigate mechanisms of cholesterol metabolism in calf hepatocytes challenged with hig...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Journal of Dairy Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022030223003703 |
_version_ | 1797774846642356224 |
---|---|
author | Wei Yang Shuang Wang Yingying Zhao Qianming Jiang Juan J. Loor Yan Tian Wenwen Fan Ming Li Bingbing Zhang Jie Cao Chuang Xu |
author_facet | Wei Yang Shuang Wang Yingying Zhao Qianming Jiang Juan J. Loor Yan Tian Wenwen Fan Ming Li Bingbing Zhang Jie Cao Chuang Xu |
author_sort | Wei Yang |
collection | DOAJ |
description | ABSTRACT: Cholesterol in the circulation is partly driven by changes in feed intake, but aspects of cholesterol metabolism during development of fatty liver are not well known. The objective of this study was to investigate mechanisms of cholesterol metabolism in calf hepatocytes challenged with high concentrations of fatty acids (FA). To address mechanistic insights regarding cholesterol metabolism, liver samples were collected from healthy control dairy cows (n = 6; 7–13 d in milk) and cows with fatty liver (n = 6; 7–11 d in milk). In vitro, hepatocytes isolated from 3 healthy female calves (1 d old) were challenged with or without a mix of 1.2 mM FA to induce metabolic stress. In addition, hepatocytes were processed with 10 µmol/L of the cholesterol synthesis inhibitor simvastatin or 6 µmol/L of the cholesterol intracellular transport inhibitor U18666A with or without the 1.2 mM FA mix. To evaluate the role of cholesterol addition, hepatocytes were treated with 0.147 mg/mL methyl-β-cyclodextrin (MβCD + FA) or 0.147 mg/mL MβCD with or without 10 and 100 µmol/L cholesterol before incubation with FA (CHO10 + FA and CHO100 + FA). In vivo data from liver biopsies were analyzed by 2-tailed unpaired Student's t-test. Data from in vitro calf hepatocytes were analyzed by one-way ANOVA. Compared with healthy cows, blood plasma total cholesterol and plasma low-density lipoprotein cholesterol content in cows with fatty liver was markedly lower, whereas the hepatic total cholesterol content did not differ. In contrast, compared with healthy controls, the triacylglycerol content in the liver and the content of FA, β-hydroxybutyrate, and aspartate aminotransferase in the plasma of cows with fatty liver were greater. The results revealed that both fatty liver in vivo and challenge of calf hepatocytes with 1.2 mM FA in vitro led to greater mRNA and protein abundance of sterol regulatory element binding transcription factor 1 (SREBF1) and fatty acid synthase (FASN). In contrast, mRNA and protein abundance of sterol regulatory element binding transcription factor 2 (SREBF2), acyl coenzyme A-cholesterol acyltransferase, and ATP-binding cassette subfamily A member 1 (ABCA1) were lower. Compared with the FA group, the cholesterol synthesis inhibitor simvastatin led to greater protein abundance of microsomal triglyceride transfer protein and mRNA abundance of SREBF2, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), ACAT2, and lower ABCA1 and FASN protein abundance. In contrast, compared with the FA group, the cholesterol intracellular transport inhibitor U18666A + FA led to greater total cholesterol concentration and greater protein and mRNA abundance of FASN. Compared with the MβCD + FA group, the addition of 10 µmol/L cholesterol led to greater concentration of cholesteryl ester and excretion of apolipoprotein B100, and greater protein and mRNA abundance of ABCA1 and microsomal triglyceride transfer protein, and lower concentration of malondialdehyde. Overall, a reduction in cholesterol synthesis promoted FA metabolism in hepatocytes likely to relieve the oxidative stress caused by the high FA load. The data suggest that maintenance of normal cholesterol synthesis promotes very low-density lipoprotein excretion and can reduce lipid accumulation and oxidative stress in dairy cows that experience fatty liver. |
first_indexed | 2024-03-12T22:27:09Z |
format | Article |
id | doaj.art-dca253e3896d434d955cfd3895d41852 |
institution | Directory Open Access Journal |
issn | 0022-0302 |
language | English |
last_indexed | 2024-03-12T22:27:09Z |
publishDate | 2023-08-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Dairy Science |
spelling | doaj.art-dca253e3896d434d955cfd3895d418522023-07-22T04:51:06ZengElsevierJournal of Dairy Science0022-03022023-08-01106858355852Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytesWei Yang0Shuang Wang1Yingying Zhao2Qianming Jiang3Juan J. Loor4Yan Tian5Wenwen Fan6Ming Li7Bingbing Zhang8Jie Cao9Chuang Xu10College of Veterinary Medicine, China Agricultural University, Haidian District, Beijing 100193, China; Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaHeilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaHeilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaMammalian NutriPhysioGenomics, Department of Animal Sciences and Division of Nutritional Sciences, University of Illinois, Urbana, IL 61801Mammalian NutriPhysioGenomics, Department of Animal Sciences and Division of Nutritional Sciences, University of Illinois, Urbana, IL 61801Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaHeilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaHeilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaCollege of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing 163319, ChinaCollege of Veterinary Medicine, China Agricultural University, Haidian District, Beijing 100193, China; Corresponding authorsCollege of Veterinary Medicine, China Agricultural University, Haidian District, Beijing 100193, China; Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China; Corresponding authorsABSTRACT: Cholesterol in the circulation is partly driven by changes in feed intake, but aspects of cholesterol metabolism during development of fatty liver are not well known. The objective of this study was to investigate mechanisms of cholesterol metabolism in calf hepatocytes challenged with high concentrations of fatty acids (FA). To address mechanistic insights regarding cholesterol metabolism, liver samples were collected from healthy control dairy cows (n = 6; 7–13 d in milk) and cows with fatty liver (n = 6; 7–11 d in milk). In vitro, hepatocytes isolated from 3 healthy female calves (1 d old) were challenged with or without a mix of 1.2 mM FA to induce metabolic stress. In addition, hepatocytes were processed with 10 µmol/L of the cholesterol synthesis inhibitor simvastatin or 6 µmol/L of the cholesterol intracellular transport inhibitor U18666A with or without the 1.2 mM FA mix. To evaluate the role of cholesterol addition, hepatocytes were treated with 0.147 mg/mL methyl-β-cyclodextrin (MβCD + FA) or 0.147 mg/mL MβCD with or without 10 and 100 µmol/L cholesterol before incubation with FA (CHO10 + FA and CHO100 + FA). In vivo data from liver biopsies were analyzed by 2-tailed unpaired Student's t-test. Data from in vitro calf hepatocytes were analyzed by one-way ANOVA. Compared with healthy cows, blood plasma total cholesterol and plasma low-density lipoprotein cholesterol content in cows with fatty liver was markedly lower, whereas the hepatic total cholesterol content did not differ. In contrast, compared with healthy controls, the triacylglycerol content in the liver and the content of FA, β-hydroxybutyrate, and aspartate aminotransferase in the plasma of cows with fatty liver were greater. The results revealed that both fatty liver in vivo and challenge of calf hepatocytes with 1.2 mM FA in vitro led to greater mRNA and protein abundance of sterol regulatory element binding transcription factor 1 (SREBF1) and fatty acid synthase (FASN). In contrast, mRNA and protein abundance of sterol regulatory element binding transcription factor 2 (SREBF2), acyl coenzyme A-cholesterol acyltransferase, and ATP-binding cassette subfamily A member 1 (ABCA1) were lower. Compared with the FA group, the cholesterol synthesis inhibitor simvastatin led to greater protein abundance of microsomal triglyceride transfer protein and mRNA abundance of SREBF2, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), ACAT2, and lower ABCA1 and FASN protein abundance. In contrast, compared with the FA group, the cholesterol intracellular transport inhibitor U18666A + FA led to greater total cholesterol concentration and greater protein and mRNA abundance of FASN. Compared with the MβCD + FA group, the addition of 10 µmol/L cholesterol led to greater concentration of cholesteryl ester and excretion of apolipoprotein B100, and greater protein and mRNA abundance of ABCA1 and microsomal triglyceride transfer protein, and lower concentration of malondialdehyde. Overall, a reduction in cholesterol synthesis promoted FA metabolism in hepatocytes likely to relieve the oxidative stress caused by the high FA load. The data suggest that maintenance of normal cholesterol synthesis promotes very low-density lipoprotein excretion and can reduce lipid accumulation and oxidative stress in dairy cows that experience fatty liver.http://www.sciencedirect.com/science/article/pii/S0022030223003703dairy cowfatty livercholesterol metabolismlipid accumulation |
spellingShingle | Wei Yang Shuang Wang Yingying Zhao Qianming Jiang Juan J. Loor Yan Tian Wenwen Fan Ming Li Bingbing Zhang Jie Cao Chuang Xu Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes Journal of Dairy Science dairy cow fatty liver cholesterol metabolism lipid accumulation |
title | Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes |
title_full | Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes |
title_fullStr | Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes |
title_full_unstemmed | Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes |
title_short | Regulation of cholesterol metabolism during high fatty acid–induced lipid deposition in calf hepatocytes |
title_sort | regulation of cholesterol metabolism during high fatty acid induced lipid deposition in calf hepatocytes |
topic | dairy cow fatty liver cholesterol metabolism lipid accumulation |
url | http://www.sciencedirect.com/science/article/pii/S0022030223003703 |
work_keys_str_mv | AT weiyang regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT shuangwang regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT yingyingzhao regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT qianmingjiang regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT juanjloor regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT yantian regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT wenwenfan regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT mingli regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT bingbingzhang regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT jiecao regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes AT chuangxu regulationofcholesterolmetabolismduringhighfattyacidinducedlipiddepositionincalfhepatocytes |